After this educational event, attendees should be able to:
Please Note: All session times are listed in Gulf Standard Time (GST).
To view the PDF version of the Scientific Programme, please click here.
To view a list of unmoderated ePosters, please click here.
To view a list of moderated and residents’ forum ePosters, please consult the Scientific Programme for those sessions.
0800-1200
SYMP-01: 9th Symposium on Affordable New Technologies in Urology (SANTU) and Best Affordable New Technologies in Urology Contest (BANTUC)
Opening SANTU-9 SANTU Lectures Relevant ePosters/Videos How to Help Medical Technology Development in Low-income Countries Relevant ePosters/Videos Practical Endourology for the Global Surgeon Relevant ePosters/Videos How to Create a Frugal Innovation Relevant ePosters/Videos The Way to Affordable Innovation Affordability Session The Unmet Need: The Genesis of the Idea How do We Develop the Cost-effective Innovations into a Product? Conundrum of Regulatory and Patent-related Issues: Developing Countries vs. Developed Countries How Can the Innovator Safeguard his Interest (Financial and Intellectual Property-related)? Q&A 4th Best Affordable New Technologies in Urology Contest (BANTUC) Presentation of 4th BANTUC Presentation of the Projects by the Finalist List Announcement of the Results and Awards Distribution of 4th BANTUC Award Distributions for the Best Moderated Poster, Best Unmoderated Poster and Best Video presentations Closing SANTU-9 and Invitation to SANTU-10, 2021 Invitation to 5th BANTUC
0800-1000
SYMP-02: Pan-African Urological Surgeons Association (PAUSA) Symposium
SESSION I: Minimally Invasive Urologic Surgery What Urologist Needs to Know About Endourologic Equipment Before Urinary Stone Treatment? Laparoscopy in Urology: Perspectives in Africa Developing Endourology in Africa, the Nigerian Experience with “NAUS- Karl Storz Endourology Roadshow’ Q&A SESSION II: General Urology Epidemiology and Types of Urinary Lithiasis in Senegal Antibiotics Resistance Pattern in Urology Patients in Western Kenya Maintaining a Scientific Basis Is Essential for Contemporary Urological Practice Q&A
0800-1000
SYMP-03: International Society of Reconstructive Urology (ISORU) Symposium
Introductioin Fossa Navicularis Stricture Non Transection Bulbar Urethroplasty 2 Stage BMG Urethroplasty Strictures in Africa Perineal Urethrostomy Expert Comments/ Q&A Setting up a Congenitilism Unit War-induced Strictures Roaming Reconstructive Urologist Hypospadias Fistula Reaching 100 cases after Fellowship Expert Comments/ Q&A Closing Remarks
0900-1200
SYMP-04: Indian Urology Around the World Symposium
Welcome Address Overcoming Challenging Problems during Flexible Ureteroscopy Dust or Bust: A Beginners Guide to Modern Day Laser Lithotripsy Srategies for Ureteroscopy Cross Fires in Urology: Pre-Emptive URS (or SWL) versus Active Surveillance for Non Obstructing 7 mm Upper Calyceal Renal Stone Pre-emptive URS: Dr. Ramesh D, Bangalore PSA of 10ng/ml as a threshold for the first biopsy: Pre-emptive URS Active Surveillance PSA of 10ng/ml as a Threshold for First Biopsy For Against Tips & Tricks in urologic Surgery (Semi-Live) Nocturia in Elderly Male - Continuing Dilemma Ureteroscopy PCNL SECOND OPINION : How to Manage a 65-year old Man with Bothersome LUTS due to BPE with Underactive Detrusor New Techniques of Treating BPH – Are They Far from Practical Reality...!? The Imaging Gap in Stone Disease - Whose Fault Is It? Black Pearls Session: Complications in Laparoscopy & Robotic Urologic Surgery Controversies in Surgical Stone Management: A Case Based Discussion Concluding Remarks
1000-1210
SYMP-05: Society of Genitourinary Reconstructive Surgeons (GURS) Symposium
Introduction TOPIC A: Male and Female Lower Urinary Tract (LUT) Reconstruction Challenges in the Management of LUT Trauma Therapeutic Challenges in Female Genitourinary Fistulae Difficult Urethral Strictures in Complex Settings (Lichen Sclerosus, Iatrogenic, and Radiation-Induced) Female Urethroplasty: Any Evidence-Based Guidelines for Treatment? Q&A TOPIC B: Troubleshooting Complications in Genitourinary Reconstruction: Learning from Our Mistakes Failed PFUI Repair Options for Failed Ureteric Reconstruction Failure of Recurrent Surgical Treatment for Post-Prostatectomy Incontinence: What Next? When Further Reconstruction is Futile in Irradiated Pelvis: The Case for Urinary Diversion Q&A TOPIC C: Challenges in Penile Prosthesis Implantation Following Penile Fracture and Trauma Penile Implantation in Transmen Following Prior IPP Infection-Erosion Q&A Closing Remarks
1250-1700
SYMP-06: Joint SIU-Chinese Urological Association (ChUA) Symposium
Welcome Bladder Infections Treatment Strategies in Recurrent UTI Treatment of UTI in Pediatric Cases Treatment of UTI in the Old and Fragile Biofilm and its Implications in Urology Bladder Cancer NMIBC Position of Biomarkers for Bladder Cancer Image 1S, NBI or PDD – Which One to Use? How to Treat BCG Failures in Intermediate Risk NMIBC Why Should You do En-bloc Resection? Bladder Cancer MIBC Is a Lymphnode Dissection Only for Staging or Also to be Curative? Uretero-enteric strictures following radical Cystectomy Bladder Sparing Treatment Chemotherapy in MIBC: When and How? Upper Tract Urothelial Cancer Differences Between Asian and Caucasian Population with UTUC Indications and Outcomes of Conservative Treatment Radical Nephroureterectomy: Still the Gold Standard? Preventive Strategies of Bladder Recurrence Following UTUC Treatment Closing Remarks
1300-1500
SYMP-07: Urological Association of Asia (UAA) Symposium
Welcome and Introduction Part 1: Urolithiasis Simulated Training in Endourology Prolonging Life of Flexible Ureteroscopes Panel Discussion: 1.5cm Upper Ureteric Stone; What’s Best in Asia? PCNL URS Laparoscopy Part 2: Advanced Urological Malignancies Precision Medicine in Prostate Cancer Decreasing Complications of Radical Cystectomy Debate: Cost versus Survival Using Advanced Therapies for Cancer Cost Matters Survival Matters Part 3: Andrology and Infertility PRP for Erectile Dysfunction Managing Peyronie’s Disease in 2021 Fertility Issues in Boys with Cancers Discussion Summary and Closing
1300-1510
SYMP-08: Kenya Association of Urological Surgeons (KAUS) and South African Urological Association (SAUA) Symposium
Welcome Use of Buccal Mucosal Graft to Repair Complex Hypospadias as Two Stage Procedure - Review of First Sixty Cases The Influence of Covid-19 Pandemic on Accessibility to TURBT Among Bladder Cancer Patients Seen at Kenyatta National Hospital, Nairobi Public and Private Partnership in Maximizing Teaching in Urology During the Covid Era Progress in Laparoscopic Urology Treatments in Kenya Genetics of Prostate Cancer Prostate Cancer Age-Standardized Incidence Increase Between 2006 and 2016 in Gauteng Province, South Africa: A Laboratory Data-Based Analysis An Update on Percutaneous Nephrolithotomy Misplaced DJ Stent Dislodged After A-H Pyeloplasty in 15-Year Old Male Take Home Message
1300-1500
SYMP-09: International Consultation on Urological Diseases (ICUD) and World Urologic Oncology Federation (WUOF) - Consultation: Molecular Biomarkers in Urology
1425-1700
SYMP-10: Joint SIU-Korean Urological Association (KUA) Symposium
Welcome Address by KUA and SIU President Endourology No Touch Technique in Ureteroscopy Hand-Assisted Laparoscopic Surgery (HALS) in Urology: Is it Still Alive? ECIRS: Indications, Tips and Tricks Discussion Oncology Pre-biopsy MRI for Prostate Cancer Screening: How Much Clinical Benefit are We Getting? Partial Nephrectomy: When Open and When Laparoscopic/Robotic Discussion Management of Advanced Bladder Cancer Pediatrics & Voiding Dysfunction Hypospadias Repair: Things Encountered During Long-term Follow-up OAB Medical Treatment Update Incontinence Treatment in Transitional Urology Adolescent Varicocele: To Treat or Not to Treat Discussion Closing Remarks
1500-1700
SYMP-11: Symposium on Focal Therapy
Introduction Focal Therapy for Renal Cancer Is Clearly Established: What Can the Prostate Counterpart Learn from It? We Identify the Index Lesion with pMRI: Current Limitations of pMRI in the Evaluation of Prostate Cancer Micro-ultrasound Guided Biopsies: Dismissing or Adding Value to mpMRI? Transitioning from MRI Fusion Biopsy to Focal Therapy Focal Therapy for PCa: What Is Really Needed to Move from Investigational to Valid Therapeutic Alternative? Tumour Microenvironment and Focal Therapy for Prostate Cancer: Are We Missing Something? Post-Focal Therapy Assessment: Biopsy and Salvage Options after Focal Therapy Recurrence Conclusion Learning Objective: Following this session, attendees will be able to foster a FT session in both renal and prostate cancer to further improve the understanding of an organ-sparing approach.
0730-1500
LS: Semi-Live Surgery
Focal Therapy and Imaging Surgeries: Micro-Ultrasound/MRI Fusion Biopsy with Real Time Visualization Focal One Treatment IRE Focal Treatment Reconstructive Surgery Surgeries: Penile Implant Urethral Repair Peyronie's Surgery Fistula Repair Endourology Surgeries: Mini PCNL plus US Single-use RIRS TUEP Aquablation Uro-oncology Surgeries: UTUC En-bloc TURBT Robotic Partial Nephrectomy Robotic Cystescomy Learning Objectives: At the end of this session, attendees will be able to:
0800-1500
TIPS-01: SIU Tips and Tricks Session
SIU Academy Social Media as an Educational Tool Cons Pros Consensus Developing a Telemedicine program: Challenges and Considerations Training in Urology in the Era of CoVID-19 and Beyond SIU Scholarships and Training Opportunities Equity and Inclusion in Urological Training Panel Discussion Break SIU Journal Introduction Urologic Publishing in 2021 Q&A The Perfect Journal Q&A Caveat Emptor: Pseudojournals in Urology Q&A The Perfect Paper Q&A The Perfect Review: Robotic Level III IVC Thrombectomy – How to Optimize Outcomes Q&A Learning Objectives: At the end of the SIU Academy session, attendees will be able to: At the end of the SIU Journal session, attendees will be able to:
0800-1730
SYMP-12: World Urological Oncology Federation (WUOF) Symposium - Advances in Systemic Therapeutics
Session One | Advanced Prostate Cancer Optimizing Treatment for Locally Advanced Prostate Cancer Molecular Imaging to Assess PCa Biology and Differentiation Genomics and Novel Markers for Identification of Inherited PCa Risk Sequencing of ARATs and Chemotherapy in CRPC Precision Medicine in CRPC ADT and Cardiovascular Disease - Myths and Misperceptions Discussion Coffee Break Session Two | Bladder Cancer Genomics of Bladder Cancer Sexual Dimorphism in Bladder Cancer - Implications for Management Novel Immunotherapies for NMIBC Tri-modal Therapy for MIBC: Role of the Urologic Oncologist Proteogenomics and Predicting Sensitivity to Chemotherapy Regionalization of Bladder Cancer Care Combined Radiation with Checkpoint Inhibitors in Bladder Cancer Bladder and Upper Tract Urothelial Cancer - Fraternal Twins or Distant Cousins Defining Options for Patients with BCG Unresponsive Disease Discussion Working Lunch Meal vouchers required for all registered attendees Session Three | Special Lecture & Town Hall The ‘C’ Words: Lessons Learned from Prostate Cancer Relevant to COVID Session Four | Kidney Cancer Population Screening for Kidney Cancer Surgical Insights for Management of Non-Clear Histology of RCC Molecular Biomarkers in RCC and Personalized Therapy DEBATE: Cytoreductive Nephrectomy in the IO era: Is it Historic or Should Most Patients With Metastatic RCC Have one? PRO CON Immune Checkpoint Inhibitor Combination Therapy in Primary Metastatic Clear-Cell RCC Discussion Session Five | PCA Localized Getting Into and Under the ‘Hood of Prostate Cancer Racial Disparities Micro-Ultrasound in the Detection and Staging of Prostate Cancer Focal Therapy: Clinical Trials to Clinical Practice How to Define Success After Focal Therapy Prostate Cancer Mythologies Diet, Nutrition, and Prostate Cancer Prevention — Is it Dead? Discussion
1000-1200
SYMP-13: Joint SIU-Confederación Americana de Urología (CAU) Session (in English)
Welcome Predictive Significance of MRI-Targeted Biopsy for Pathological and Oncological Outcomes Surgical Quality Assessment in Radical Prostatectomy. Lessons from Patient Reported Outcomes The Impact of 3-D Model and Improved Imaging in Renal Cancer Surgery Small Renal Masses Treatment for Lesions Under 4 cm. It Cannot Be Only Surgery! Recent Evolution in Localized Bladder Cancer Treatment Recent Evolution in Advanced Bladder Cancer Treatment Conclusion To foster a Urologic Oncology session showing the latest advances in prostate, kidney, and bladder cancers with a perspective from an active Urologist in the CAU. To improve the understanding of an organ sparing approach the latest advances in prostate, kidney, and bladder cancers.
1000-1200
SYMP-14: Arab Urology Around the World (AAU) Symposium
Welcome Remarks Endo of Stone Age Robotic Management of Urolithiasis Lithotripsy in Percutaneous Nephrolithotomy Laser Prostatectomy: Developing Countries’ Perspectives Management of Glans Deformities Following Penile Prosthesis Insertion Male Hypogonadism - Lecture Title TBC Difficult Surgical Decisions in RCC Practice-Changing Advances in Bladder Cancer in 2021 The Role of Surgery in Bladder Cancer Patients with Lymph Lode Metastasis Urology Training in the Arab World: Example from Kuwait Institute for Medical Specialization (KIMS) Closing Remarks
1000-1300
SYMP-16: Joint SIU-Federation of ASEAN Urological Associations (FAUA) Session
Welcome Remarks Part 1: Reconstructive Surgery in Urology - Establishing Reconstructive Urology Service in South East Asia (SEA) Reconstructive Urology Conundrum in Subsaharan Africa Collaboration in Reconstructive Urology for South East Asia (SEA) The Challenge in Establishing Reconstructive Service in Daily Practice How to Start and Learn from Mistakes in Reconstructive Urology Part 2: Transplant Urology Services Laparoscopy Donor Nephrectomy Early Urological Complications of Live Related Renal Transplant: How to Prevent and Solve Them Transplant Program in Malaysia Robot Assisted Laparoscopic Living Donor Nephrectomy at Cho Ray Hospital Part 3: Laparoscopic and Robotic Surgery in Urology in SEA Robotic Prostatectomy: Worth the Cost? Singapore Experience with Retzius Sparing Radical Prostatectomy: Why I Stopped Current Status of Robotic Uro-oncological Surgery in Thailand Early Experience of Robotic Assisted Lap RPLND Closing Remarks
1300-1500
SYMP-15: Iranian Urological Association (IUA) Symposium
Bladder Cancer: Peri-operative Considerations in Radical Cystectomy Bladder Cancer: Neo-adjuvant Treatments Q&A Adrenal Mass: Diagnosis and Preoperative Evaluation Laparoscopy for Adrenal Surgery Q&A Panel: Nightmares in Endourology
1300-1500
SYMP-17: International Neuro-Urology Society (INUS) Symposium
Pathophysiology of Neurogenic Lower Urinary Tract Dysfunction and Its Terminology – An Update the Role of Urodynamics in Neurogenic Lower Urinary Tract Dysfunction Management Strategies for the Most Frequent Types of Neurogenic Lower Urinary Tract Dysfunction in 2021 Discussion Neurogenic Urinary Incontinence - Different Pathophysiologies, Different Treatment Strategies Discussion Refractory OAB: Electrical Neuromodulation vs. Botulinumtoxine A – A Point-and-Counterpoint Discussion Discussion & Closing
1500-1700
SYMP-18: Hellenic Urological Association (HUA) Symposium - Current Status and Future Directions in the Treatment of RCC
Introduction Renal Biopsy: Where do We Stand? Surveillance in Small Renal Masses NSS for Small Renal Masses (SRMs) Cytoreductive Nephrectomy in the CARMENA Era Smashing News in Systemic Therapy Discussion/Q&A
1500-1700
SYMP-19: EurAsian Urooncology Association (EUA) Symposium
Introduction The Rationale for Cystectomy in Patients with T1HG Bladder Cancer Decision/diagnosis of MIBC by whom? Radiologist vs Pathologist vs Urologist. Robot Assisted Cystectomy and Intracorporeal Diversion New Trends on Urinary Diversion Choice Immunotherapy in Bladder Cancer Closing Remarks
1700-1830
OC: Opening Ceremonies
0730-0900
IC-01: Instructional Course 01 - PCNL Tips/Tricks and Pitfalls
How to Optimize the Patient Pre-Op Q&A How to Simply Perform Miniaturized PCNL Q&A How to Efficiently and Safely Perform Standard PCNL Q&A The Do's and the Don'ts in Nightmare Cases: Vote for the Best Option! Q&A Discussion & Take Home Messages Learning Objectives: At the end of this session, attendees will be able to:
0755-0900
MC-01: Master Class 01 - Advanced Kidney Cancer
Introduction New Systemic Therapies in Advanced RCC Discussion Rationale for Combining Surgery and Systemic Therapy Discussion Cases in Advanced RCC – Clinical Practice Discussion What Trials Do We Need in Advanced RCC to Improve Outcomes Discussion Take-Home Messages Learning Objectives: At the conclusion of this course, attendees will be able to:
0800-0900
MC-02: Master Class 02 - Refractory Overactive Bladder Syndrome
Introduction Definition and Evaluation of the Refractory Overactive Bladder: New Drugs in the Armamentarium Current Efficacy and Limitations of Neuromodulation Current Efficacy and Limitations of Intravesical Botulinum Toxin: New Ideas for Delivery on the Horizon Future Ideas and Devices for Refractory Bladder Case-Based Discussion Q&A Summary
0900-1030
DEMO: Demo Session: Tips and Tricks in fURS
Pre-registration is required for this session This session will focus more on endourological procedures (RIRS and PCNL) in terms of instrumentation, technique and tips and tricks. Learning Objectives
0900-1200
INN-01: Prostate MRI Reading and Fusion Biopsy Hands On Training Course
0900-1045
PL-01: Plenary 01
Welcome Introduction to SIU-Mostafa M. Elhilali Award Lecture 2020 and 2021 SIU-Mostafa M. Elhilali Award Lectures 2020 Award Winner [Lecture Title TBC] 2021 Award Winner - Lecture Title: The Butcher, the Baker and the Ice-cream Maker – a Personal Reflection on Prostate Cancer Treatment over the Last Decade Emirates Urological Society (EUS) Lecture: Oxidative Stress and Male Infertility Learning Objectives: Pan African Urological Association (PAUSA) Lecture: Challenges and Opportunities in Urethral Reconstruction in Sub Saharan Africa State-of-the-Art Lecture: Genetics of Bladder Cancer Learning Objectives: State-of-the-Art Lecture: Novel Therapies in RCC and the Impact on Surgery
1045-1115
Break
1045-1245
TIPS-02: SIU Tips and Tricks Session
1115-1245
HT-01: Hot Topics 01 - Harnessing Artificial Intelligence (AI) in Urology
Introduction The Future of Prostate Cancer Imaging; Will AI Play a Role? The Quantified Surgeon: Predicting Patient Outcomes after Robotic Surgery and Automating Skills Assessment 3D Models to Enhance the Quality of Robotic Assisted Partial Nephrectomy Ethical and Legal Considerations of Using Artificial Intelligence in Healthcare Q&A Closing Remarks Learning Objectives:
1115-1245
HT-02: Hot Topics 02 - PSMA Theranostics
Introduction Initial Staging with PSMA Role of Targeted Salvage Surgery in Biochemical Recurrence (BCR) Role of Targeted Salvage Radiation and Metastasis-directed Therapy in Biochemical Recurrence (BCR) Role of PSMA PET in mCRPC and PSMA-RLT Q&A and Discussion Take-home Messages Learning Objectives: At the conclusion of this course, attendees will be able to:
1115-1245
IC-03: Instructional Course 03 - Imaging-Guided Biopsy Diagnostic Pathway in Prostate Cancer
Interpreting Multiparametric MRI Q&A What is the Evidence for MRI in the Diagnostic Pathway of Prostate Cancer? Q&A Establishing an Image-Guided Biopsy Program Q&A Clinical Dilemmas: Case-Based Panel Discussion Q&A Learning Objectives: At the conclusion of this course, attendees will be able to:
1115-1245
IC-04: Instructional Course 04 - Novel BPH Therapies – Review of Technologies and Practical Instruction (Laser EEP, UroLift, Rezum, Aquablation, Stents)
Introduction to Novel BPH Therapies Laser Transurethral Endoscopic Enucleation of the Prostate (EEP) Q&A UroLift Q&A Rezum Q&A Aquablation Q&A Stents Q&A Closing Remarks Learning Objectives: At the end of this session, attendees will be able to:
1115-1245
JS-01: Joint SIU-Endourological Society Session
Introduction Session 1: How I Do It – Tips & Tricks, Technique Videos Nerve Sparing in Radical Prostatectomy IVC Incision in Level 1 IVC Thrombus Rt Robotic Radical Nephrectomy Treatment of Upper Tract TCC by FURS - Key Points for Success ThuLEP - Why I Prefer it Treatment of Lower Calyx Stone by RIRS ECIRS – Key Points for Success Session 2: State-of-the-Art Lectures Focal Therapy for Renal Tumors Ureteral Stent – What is the Future? Session 3 – Debate Is SWL Out of the Armamentarium of Modern Urology Yes No Holmium Laser for Stone is on Death Bed Yes No Closing Remarks Learning Objectives: At the end of this session, attendees will be able to:
1115-1245
MP-01: Moderated ePoster Session 01 - Bladder Cancer
1115-1245
MP-02: Moderated ePoster Session 02 - Pediatrics/ Miscellaneous/ Basic Science
1115-1245
JS-02: Joint SIU-International Society of Reconstructive Urology (ISORU) Session
Introduction Hypospadias Surgery Radiation and Urethral Problems Gender Reassignment Vessel Sparing Posterior Urethroplasty Complex Urethroplasty Ask the Experts Learning Objectives: At the end of this session, attendees will be able to:
1245-1415
Lunch Break
1400-1700
SYMP-20: Emirates Urological Society (EUS) Symposium
1415-1545
IC-05: Instructional Course 05 - Urological Care for Transgender Patients
Introduction Vaginoplasty: Preparation, Surgical Anatomy, Follow-up, Oncological Considerations Vaginoplasty Complications, Evaluation and Management Discussion, Q&A Phalloplasty: Preparation, Surgical Anatomy, Prosthetics, Follow-up Metoidioplasty: Preparation, Surgical Anatomy, Follow-up Phalloplasty and Metoidioplasty Complications and Management General Urological Considerations in Care for Transgender Patients Discussion, Q&A Learning Objectives; At the end of this session, attendees will be able to:
1415-1545
IC-06: Instructional Course 06 - Minimally-Invasive PCNL (Mini-PCNL): The Way Forward
Percutaneous Access with Ultrasonograpy and Fluoroscopy Guidance Positioning - Prone or Supine, Single Step Tract Dilation Use of Various Energy Sources for Stone Fragmentation Novel Concept-Suction in mini-PCNL - ‘Super mini-perc’ Flexible mini-PCNL and Various Exit Strategies Case-Based Discussion and Q&A Learning Objectives: At the end of this session, attendees will be able to:
1415-1545
IC-07: Instructional Course 07 - Focal Therapy for Locoregional or Oligometastatic Recurrence of Prostate Cancer
Definition of Locoregional or Oligometastatic Recurrence and Case Presentation Systemic Therapy Radiotherapy Surgery Focal Therapy Q&A and Discussion Closing Remarks Learning Objectives: At the end of this session, attendees will be able to:
1415-1545
MV-01: Master Videos 01 - Genitourinary Fistulae
Introduction Abdominal Approach Vaginal Approach Laparoscopic Repair Robotic Repair Clinical Cases Discussion Take-Home Messages Learning Objectives: At the end of this session, attendees will be able to:
1415-1545
MP-03: Moderated ePoster Session 03 - Infections & Inflammatory Disease
1415-1545
MVP-01: Moderated Video Session 01 - BTO/LUTS, Miscellaneous, Pediatric Urology, Reconstruction
1415-1715
INN: SIU Innovators' Symposium
Part 1: Telemedicine At the end of this session, attendees will be able to: How to Have a Successful Telemedicine Encounter Remote Patient Monitoring- How to Optimize Follow-up Strategies in Urology (Oncology vs Non-oncology) Current Apps Available on The Market and How to Optimize Them Q&A Debate on EMR vs Taditional Paper Charts For Paper Charts For EMR Discussion Part 2: Telementoring At the end of this session, attendees will be able to: Improve knowledge on current mentoring options and facilitation of networking for surgical/medical skills improvement Current Platforms for Life Surgical Mentoring. Why Should we Promote Telementoring? Pros and Cons Real-Life Experience on Urology Telementoring - What to Expect? Q&A Break Part 3: Urology Equity - You Cannot Be What You Cannot See: Promoting Equity in Surgery At the end of this session, attendees will be able to: Current Status of Gender Equity per Continent. Current Analysis as per EAU/SIU/AUA Membership Office Academic Opportunities: Establishing Mentorship Programmes to Promote Equity Q&A Part 4: Planning Clinical Trials How to Set up a Primary Endpoint for a Clinical Trial in Oncology/Non-Oncology How to Introduce New Drug/Surgical Treatments in Asia Strategies to Obtain FDA/EMA Approval: Rationale for Trial Design Learning Objectives: At the end of this session, attendees will be able to:
1545-1615
Break
1615-1745
IC-08: Instructional Course 08 - Case Based Discussions in Neuro-urology
Introduction Suprasacal Spinal Cord Injury (SCI) – Case-Based Discussion Spina Bifida – Case-Based Discussion Multiple Sclerosis – Case-Based Discussion Q&A and Discussion Conclusions Learning Objectives: At the conclusion of this course, attendees will be able to:
1615-1745
IC-09: Instructional Course 09 - Complex Penile and Urethral Reconstruction in Adults with Prior Hypospadias or Epispadias
Introduction Hypospadias in Adults - Primary Repair Late Complication of Hypospadias Re-Doing Epispadias After Failed Surgery in Childhood Penile Curvature in Adults: Peyronie’s Disease or Congenital? Q&A and Discussion Conclusions Learning Objectives: At the end of this session, attendees will be able to:
1615-1745
IC-10: Instructional Course 10 - Evolving Treatment Landscape of Cancer: Immunotherapy in Urological Cancer
Opening Remarks Immunology ABC Immunotherapy of Urothelial Cancer: Practice Changing or Changing Practice? Immunotherapy of Renal Cell Carcinoma: More Is Better? Or Sequencing Matters? Immunotherapy of Prostate Cancer: Meeting Unmet Needs? Harmonize Patient Care with Management of Immune-Related Complications Checkpoint Inhibitors: Understanding Side Effects through a Case-Based Discussion Panel Discussion and Conclusion Learning Objectives: At the end of this session, attendees will be able to:
1615-1745
MV-02: Master Videos 02 - Endoscopic Surgery for BPH: Compare and Contrast
Aquablation Urolift: Minimally Invasive Surgical Procedures for LUTS due to BPO: Focus on PUL Various Endoscopic Enucleation Procedures in Europe Enucleation by Holmium Laser (HoLEP) BipolEP Q&A + Panel Discussion Take‐home Message Learning Objectives: At the conclusion of this course, attendees will be able to:
1615-1750
IS-01: Interactive Session 01 - Open Surgery in 2021: When and Why?
Introduction Open Surgery in Bladder Cancer Case Discussion 1 (with Audience Participation) Bladder Cancer Open Retroperitoneal Lymph Node Dissection (RPLND) Case Discussion 2 (with Audience Participation) Testicular Cancer Open Surgery in Renal Cell Carcinoma (RCC) Case Discussion 3 (with Audience Participation) Kidney Cancer Trans-perineal Radical Prostatectomy Case Discussion 4 (with Audience Participation) Prostate Cancer Closing Remarks Learning Objectives: At the end of this session, attendees will be able to:
0700-0800
GA: General Assembly
0730-0900
IC-11: Instructional Course 11 - Bleeding Complications of PCNL - Prevention & Management
Introduction Etiological Factors Leading to Bleeding Complication – Pre, Intra & Post-op Intra-op Excessive Bleeding – How to Tackle Post-op Bleeding – Step-by-Step Management Preventing Steps to Reduce Bleeding Complications in PCNL Case-Based Discussion Learning Objectives: At the end of this session, attendees will be able to:
0730-0900
IC-12: Instructional Course 12 - Tools to Make Caring for Pelvic Pain Easier and More Successful for the Urologist
Introduction Solicitation of Audience Needs Differential Diagnosis and Triage of Localized Pelvic Pain Overview of Musculoskeletal Pelvic Pain: Specific Strategies When Systemic Pain is a Factor: What to Do with These Patients? Presentation of Difficult Cases by Audience, Q&A Learning Objectives: At the end of this session, attendees will be able to:
0730-0900
IC-13: Instructional Course 13 - PDE 5 Inhibitor Non-Responders for Erectile Dysfunction
Definition, Incidence, Causes and Aetiopathogenesis History and Investigations Medical Treatment- Mono and Polytherapy Role of Testosterone Deficiency & Replacement Therapy Minimally Invasive Therapy: Recent Advances in Management Key Take-home messages, Questions & Answers Learning Objectives: At the end of this session, attendees will be able to:
0800-0900
MC-03: Master Class 03 - Geriatric Urology
Introduction How to Evaluate for Pre-operative Frailty? Risk Sratification and its Implications Detrusor Underactivity in Aging Patients: Evaluation and Management Urogenital Problems After Menopause: Effects of Oestrogen Replacement Bladder Outlet Obstruction in the Frail Elderly Patient: My Approach to Management Take-home Message Learning Objectives:
0800-0900
MC-04: Master Class 04 - Genital Emergencies
Introduction Pathophysiology and Clinical Diagnostic Approach Medical Management of Ischemic Priapism Novel Strategies for The Management of Ischemic Priapism Penile Implant for Ischemic Priapism Challenging Case Scenarios Q&A Learning Objectives:
0800-1600
NURS: 6th SIU Global Nurses' Educational Symposium
Welcome Diagnosis and Treatment of Bladder Cancer Ostomy Management ERAS: Enhanced Recovery After Surgery Compliance with Erectile Dysfunction Treatment in Men with Prostate Cancer Case Study and Clinicians’ Experiences: Nursing Support for Patients with Sexual Dysfunction Infection Control for Penile Implantation Break and ePoster Poster Viewing BPH/LUTS Treatment Nursing Considerations for Patients with Urinary Symptoms Nursing Practice Related to Intermittent Catheterization Evidence-Based Practice Q&A Abstract Presentations Break and ePoster Viewing The Role of Imaging and Novel Biomarkers to Guide Active Surveillance Considerations When Performing Prostate Biopsies Urodynamic Setup Interpretation and Artifacts Neuromodulation Q&A Therapeutic Modalities and Management of Complex Stone Disease Operating Room Settings for Stone Surgery (PCNL, Ureteroscopy with Lithotripsy) Laser Safety in Surgery – General Safety and Specific Requirements in OT Urosepsis Use of Chlorhexidine 0.1% for Urethral Cleaning in Pre- and Post- Foley’s Catheter Insertion (Evidence-Based Practice) Structuring Skin Care to Prevent Incontinence Associated Dermatitis Comparative Study of Incontinence Associated Dermatitis Treatments- (Evidence-based practice) Q&A Meeting Close and Invitation to 7th SIU Global Nurses' Educational Symposium Learning Objectives: At the end of this session, attendees will be able to:
0900-1030
DEMO: Demo Session: Tips and Tricks in fURS
Pre-registration is required for this session This session will focus more on endourological procedures (RIRS and PCNL) in terms of instrumentation, technique and tips and tricks. Learning Objectives
0900-1045
PL-02: Plenary 02
Welcome and SIU Academy Awards Presentation State-of-the-Art Lecture: Is it Time to Revisit Prostate Cancer Screening? Learning Objectives: At the end of Dr. Emberton's lecture, attendees will be able to: State-of-the-Art Lecture: The Role for the General Urologist in the Era of Subspecialization Confederación Americana de Urología (CAU) Lecture: Symptomatic BPH - Present Surgical Options for an Ageing Problem Learning Objectives: Urological Association of Asia (UAA) Lecture: Technological Evaluation of Renal Puncture for Endoscopic Surgery Learning Objectives: Panel on Transitional Urology Learning Objectives: At the conclusion of this course, attendees will be able to:
0900-1200
INN-02: Prostate MRI Reading and Fusion Biopsy Hands On Training Course
1045-1115
Break
Wednesday, November 10
Please click on the session titles to view the session details when available.
Honorary Chair: Daniel Yachia, Israel
0800-0805
0805-0830
Abdulrahman Al Aown, Saudi Arabia
Rami Labib, United Arab Emirates
Satâa Sallami, Tunisia
Egon Ilman Saputra, Indonesia
J. J. Thakkar, Kenya
0830-0845
0845-0855
Christian Agbo Agbo, Nigeria
Ammar Alanbuki, United Kingdom
Vineet Gauhar, Singapore
Naveed Haroon, Pakistan
Ahmed Loghmari, Tunisia
0855-0910
0910-0920
Seshu Mohan Khetavath, India
Abdelouaheb Mellouk, Algeria
Gaurav Srivastava, United Kingdom
0920-0935
0935-0945
Jasamine Coles-Black, Australia
Wissam Kamal, Saudi Arabia
Yoshitsugu Nasu, Japan
0945-1000
1000-1010
1010-1020
1020-1030
1030-1040
1040-1050
1050-1055
1055-1145
1145-1150
1150-1155
1155-1158
1158-1200
Alex Danso, Zimbabwe
Alexander M.E. Nwofor, Nigeria
0800-0820
0820-0835
0835-0850
0850-0900
Serigne Magueye Gueye, Senegal
Cyril Kamadjou, Cameroon
0900-0920
0920-0935
0935-0950
0950-1000
0800-0805
0805-0814
0814-0823
0823-0832
0832-0841
0841-0850
0850-0900
0900-0909
0909-0918
0918-0927
0927-0936
0936-0945
0945-0955
0955-1000
0900-0905
Christopher Evans, United States
0905-0915
0915-0925
Active Surveillance: Dr. Harprit Singh, Jamshedpur
For: Dr. Gagan Gautam, New Delhi
Against: Dr. Raghunath, Bangalore
0925-0932
0932-0940
0940-0947
0947-0955
1025-1035
0955-1005
1005-1015
1015-1025
1035-1045
1045-1055
1055-1120
Mallikarjuna Chiruvella, India
Arvind Ganpule, India
Sudhir Rawal, India
1120-1155
Moderators
Keshavamurthy Ramaiah, India
Ravindra Sabnis, India
Panelists
Arun Chawla, India
S. K. Pal, India
Kandarp Parikh, India
1155-1200
1000-1002
Jairam Eswara, United States
Francisco E. Martins, Portugal
1002-1012
1012-1022
1022-1032
1032-1042
1042-1047
1047-1057
1057-1107
1107-1117
1117-1127
1127-1132
1132-1142
1142-1152
1152-1202
1202-1207
1207-1210
Jairam Eswara, United States
Francisco E. Martins, Portugal
1250-1300
Jean de la Rosette, Turkey
1300-1315
1315-1330
1330-1345
1345-1400
Tianxin Lin, People's Republic of China
Ahmet Yaser Müslümanoğlu, Turkey
Miguel Ramos, Portugal
Chuanliang Xu, China
1400-1415
1415-1430
1430-1445
1445-1400
Patrick Coloby, France
Richard Hautmann, Germany
Tianxin Lin, People's Republic of China
Chuanliang Xu, China
1500-1515
1515-1530
1530-1545
1545-1600
Mallikarjuna Chiruvella, India
Michael Grasso, United States
Lulin Ma, China
Tao Xu, People's Republic of China
1600-1615
1615-1630
1630-1645
1645-1700
1700-1705
Li-Ping Xie, People's Republic of China
1300-1305
1305-1313
1313-1321
1321-1345
1345-1353
1353-1401
1401-1425
1425-1433
1433-1441
1441-1449
1449-1455
1455-1500
1300-1305
Saeed R. Samnakay, Kenya
Simon Tanguay, Canada
1305-1320
1320-1335
1335-1350
1350-1405
1405-1420
1420-1435
1435-1450
1450-1505
1505-1510
Saeed R. Samnakay, Kenya
1425-1430
Sang Don Lee, South Korea
Marin Georgiev, Bulgaria
Ill Young Seo
1430-1515
1440-1450
1450-1500
1500-1515
Petrisor Aurelian Geavlete, Romania
Sunghyun Paick, South Korea
Daniel Pérez-Fentes, Spain
Arturo Mendoza-Valdes, Mexico
Ho Kyung Seo, South Korea
1515-1525
1525-1535
1545-1600
Archil Chkhotua, Georgia
U-Syn Ha, South Korea
Sung Kyu Hong, South Korea
Tae-Hwan Kim, South Korea
Seong Il Seo, South Korea
1535-1545
Abdolmohammad Kajbafzadeh, Iran
Sang Don Lee, South Korea
1600-1610
1610-1620
1620-1630
1630-1640
1640-1655
M. Ihsan Karaman, Turkey
Jang Hwan Kim, South Korea
Martin Michel, Germany
Kwan Jin Park, South Korea
Hwancheol Son, South Korea
1655-1700
Sang Don Lee, South Korea
1500-1507
Jurgen Futterer, The Netherlands
Rafael Sanchez-Salas, Canada
1507-1522
1522-1537
1537-1552
1552-1607
1607-1622
1622-1637
1637-1652
1652-1700
Jurgen Futterer, The Netherlands
Rafael Sanchez-Salas, Canada
Thursday, November 11
Please click on the session titles to view the session details when available.
0730-0900
Jurgen Futterer, The Netherlands
Mauro Gacci, Italy
Sung Kyu Hong, South Korea
Rahim Horuz, Turkey
Ka Lun Lo, China
Armando Stabile, Italy
Rafael Tourinho-Barbosa, Brazil
0900-1100
Avelino Fraga, Portugal
Reynaldo Gómez, Chile
Serigne Magueye Gueye, Senegal
Sang Don Lee, South Korea
Kurt McCammon, United States
Ingrid Perscky, Panama
André van der Merwe, South Africa
1100-1300
Abdullatif Al-Terki, Kuwait
Anastasios Anastasiadis, Greece
Melanie Aube-Peterkin, Canada
Vincent De Coninck, Belgium
Vineet Gauhar, Singapore
Sanjay Khadgi, Nepal
Thomas Tailly, Belgium
1300-1500
Piotr Chlosta, Poland
Mahesh R. Desai, India
Andrés Hernández-Porras, Mexico
Markus Hohenfellner, Germany
Pilar Laguna, Turkey
Richard Mallet, France
Poongkodi Nagappan, Malaysia
0800-1000
Sean P. Elliott, United States
Stavros Gravas, Cyprus
0800-0830
0830-0845
0845-0900
0900-0915
0915-0930
0930-1000
1000-1300
1300-1500
1300-1305
1305-1320
1320-1328
1328-1343
1343-1351
1351-1406
1406-1414
1414-1429
1429-1437
1437-1452
1452-1500
0800-1015
0815-0830
0830-0845
0845-0900
0900-0915
0915-0930
0930-0945
0945-1015
1015-1030
1030-1300
1035-1050
1050-1105
1105-1120
1120-1135
1135-1150
1150-1205
1205-1220
1220-1235
1235-1250
1250-1300
1300-1330
1330-1355
1355-1410
1410-1545
1410-1425
1425-1440
1440-1455
1455-1520
Ricardo Rendon, Canada
Ricardo Rendon, Canada
1520-1535
1535-1545
1545-1730
1545-1600
1600-1615
1615-1630
1630-1645
1645-1700
1700-1715
1715-1730
1000-1005
1005-1023
1023-1041
1041-1101
1101-1119
1119-1137
1137-1155
1155-1200
1000-1009
Yasser Farahat, United Arab Emirates
Rajeev Kumar, India
1009-1021
1021-1033
1033-1045
1045-1057
1057-1109
1109-1121
1121-1133
1133-1145
1145-1157
1157-1209
1209-1215
1000-1010
Teng Aik Ong, Malaysia
Arun Chawla, India
Paksi Satyagraha, Indonesia
1010-1025
1025-1040
1040-1055
1055-1110
Moderator: Mahesh R. Desai, India
1110-1125
1125-1140
1140-1155
1155-1210
Simon Tanguay, Canada
Noor Ashani Bin Md. Yusoff, Malaysia
1210-1225
1225-1240
1240-1255
1255-1310
1310-1315
Noor Ashani Bin Md. Yusoff, Malaysia
1300-1310
1310-1320
1320-1330
1330-1340
1340-1350
1350-1400
1400-1500
Panelists
Leye Ajayi, United Kingdom
Anastasios Anastasiadis, Greece
Vincent De Coninck, Belgium
Kandarp Parikh, India
1300-1315
1315-1330
1330-1345
1345-1400
1400-1415
1415-1420
1420-1440
Thomas Kessler, Switzerland
1440-1500
1500-1505
Mohamad Moussa, Lebanon
1505-1525
1525-1545
1545-1605
1605-1625
1625-1645
1645-1700
Ioannis Gkialas, Greece
Stavros Gravas, Cyprus
Mohamad Moussa, Lebanon
Athanasios Papatsoris, Greece
Petros Sountoulides, Greece
1500-1510
Ahmet Yaser Müslümanoğlu, Turkey
1510-1530
1530-1550
1550-1610
1610-1630
1630-1650
1650-1700
Ahmet Yaser Müslümanoğlu, Turkey
Friday, November 12
Please click on the session titles to view the session details when available.
0730-0745
0750-0805
0805-0810
0810-0825
0825-0830
0830-0845
0845-0850
0850-0900
Athanasios Papatsoris, Greece
0755-0757
Peter Mulders, The Netherlands
0757-0807
0807-0812
0812-0822
0822-0827
0827-0837
0837-0842
0842-0852
0852-0855
0855-0900
Peter Mulders, The Netherlands
0800-0802
0802-0812
0812-0822
0822-0832
0832-0842
0842-0852
Sanjay Sinha, India
Alan Wein, United States
David Manuel Castro Díaz, Spain
0852-0858
0858-0900
0900-0905
0905-0910
0910-0940
0940-0955
At the end of Dr. Kandil's lecture, attendees will be able to:
0955-1010
1010-1025
At the end of Dr. Lerner's lecture, attendees will be able to:
1025-1040
1115-1120
Quoc-Dien Trinh, United States
1120-1138
1138-1156
1156-1214
1214-1232
1232-1240
1240-1245
Quoc-Dien Trinh, United States
At the end of this session, attendees will be able to:
1115-1117
Tobias Maurer, Germany
1117-1136
1136-1155
1155-1214
1214-1233
1233-1243
1243-1245
Tobias Maurer, Germany
1115-1127
1127-1130
1130-1142
1142-1145
1145-1157
1157-1200
1200-1230
Panelists
Marc Dall'Era, United States
Pieter De Visschere, Belgium
Caroline Moore, United Kingdom
1230-1245
Panelists
Marc Dall'Era, United States
Pieter De Visschere, Belgium
Caroline Moore, United Kingdom
1115-1120
1120-1132
1132-1136
1136-1148
1148-1152
1152-1204
1204-1208
1208-1220
1220-1224
1224-1236
1236-1240
1240-1245
1115-1120
1120-1126
1126-1132
1132-1138
1138-1144
1144-1150
1150-1156
1156-1203
1203-1210
1210-1224
1224-1238
1238-1245
1115-1118
Sanjay Kulkarni, India
1118-1133
1133-1148
1148-1203
1203-1218
1218-1233
1233-1245
Miroslav Djordjevic, Serbia
Reynaldo Gómez, Chile
Sanjay Kulkarni, India
Richard Santucci, United States
1415-1420
1420-1435
1435-1445
Richard Santucci, United States
1445-1445
1455-1510
1510-1520
1520-1530
1530-1535
1535-1545
1415-1435
1435-1450
1450-1500
1500-1515
1515-1525
1525-1545
1415-1420
1420-1435
1435-1450
1450-1505
1505-1520
1520-1540
Pierre Blanchard, France
Rafael Sanchez-Salas, Canada
Ricardo Soares, United States
1540-1545
1415-1420
1420-1435
1435-1450
1450-1505
1505-1520
1520-1540
1540-1545
1415-1500
Sophie Rintoul-Hoad, United Kingdom
Evanguelos Xylinas, France
1415-1420
1420-1425
1425-1430
1430-1435
1435-1445
Nathan Lawrentschuk, Australia
1500-1545
Melanie Aube-Peterkin, Canada
Dean Elterman, Canada
1500-1520
1520-1540
James Porter, United States
1540-1545
1545-1600
1600-1630
1600-1612
1612-1625
1625-1630
1630-1715
1630-1645
1645-1700
1700-1715
1615-1620
1620-1640
1640-1700
1700-1720
1720-1740
1740-1745
1615-1620
1620-1635
1635-1650
1650-1705
1705-1720
1720-1740
1740-1745
Define modalities of hypospadias surgery in adult patients
Recognize complications of hypospadias treatment and different surgical approaches for their resolution
Recognize most important surgical steps in re-do epispadias repair; define and achieve successful outcome
Recognize penile curvature in adults as a consequence of Peyronie's disease or congenital deformity
Conduct good postoperative care and treatment.
1615-1620
1620-1632
1632-1644
1644-1656
1656-1708
1708-1720
1720-1732
1732-1745
1615-1630
1630-1645
1645-1700
1700-1715
1715-1730
Dimitrios Staios, Greece
1730-1740
Javier Sanchez Macias, Spain
Vincent Misrai, France
Athanasios Papatsoris, Greece
Dimitrios Staios, Greece
Anil Kumar Varshney, India
1740-1745
Anil Kumar Varshney, India
1615-1620
Amlesh Seth, India
1620-1635
1635-1642
1642-1657
1657-1704
1704-1719
1719-1726
1726-1741
1741-1748
1748-1750
Amlesh Seth, India
Saturday, November 13
Please click on the session titles to view the session details when available.
0730-0735
0735-0750
0750-0805
0805-0820
0820-0835
0835-0900
Panelists
Michael Borofsky, United States
Jean de la Rosette, Turkey
Brian Matlaga, United States
0730-0735
0735-0740
0740-0800
0800-0820
0820-0840
0840-0900
0730-0745
0745-0800
0800-0815
0815-0830
0830-0845
0845-0900
0800-0802
0802-0816
0816-0830
0830-0844
0844-0858
0858-0900
At the end of this session, attendees will be able to:
0800-0802
Rupin Shah, India
0802-0810
0810-0820
0820-0830
0830-0835
0835-0850
0850-0900
Asif Muneer, United Kingdom
Rupin Shah, India
Faysal Yafi, United States
At the end of this session, attendees will be able to:
0800-0805
Amparo Gudrun Camacho, United States
0805-0830
0830-0850
0850-0910
0910-0935
0935-1000
1000-1015
1015-1030
1030-1055
1055-1105
1105-1115
1115-1120
Marcerey Sison Quejada, United Arab Emirates
1120-1200
Amparo Gudrun Camacho, United States
Mariezl Fonbuena, United Arab Emirates
1200-1250
1250-1315
1315-1340
1340-1350
1350-1400
1400-1410
1410-1415
1415-1440
1440-1455
1455-1510
1510-1535
1535-1545
1545-1555
1555-1605
1605-1610
Marcerey Sison Quejada, United Arab Emirates
1610-1615
Amparo Gudrun Camacho, United States
0900-0915
0915-0930
0930-0945
0945-1000
At the end of Dr. Rodríguez's lecture, attendees will be able to:
1000-1015
At the end of Dr. Hamamoto's lecture, attendees will be able to:
1015-1045
Faculty
Rizwan Hamid, United Kingdom
Dan Wood, United Kingdom